Ian Peikon
Venture Partner @ Lux Capital
New York, United States
Ian Peikon is a seed investor at Lux Capital in New York focused on Biotechnology and Pharmaceutical. Ian is a molecular biologist, engineer, and entrepreneur. He has been involved in the formation and early company building of Lux portfolio companies including Kallyope as well as several other stealth Newcos.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Ian Peikon invests in
Stages Ian Peikon invests in
Countries Ian Peikon invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease. | $96M / Series A / Nov 29, 2022 | ||
| Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease. | Seed |
Co-Investors
About Lux Capital
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Lux Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Kalish
General Partner
|
|||
Alex Nguyen
Principal
|
|||
Brandon Reeves
Partner
|
|||
Deena Shakir
General Partner
|
|||
|
Ian Peikon
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ian Peikon invest in?
Ian Peikon invests primarily in Biotechnology and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ian Peikon?
Public channels for Ian Peikon include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ian Peikon last invest?
The most recent investment recorded for Ian Peikon closed in Nov 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
